Authors


John Luo, MD

Latest:

Turning a Negative Into a Positive: Ways to Avoid and Overcome Negative Reviews

The Internet has transformed the way we get information. It is no surprise that finding health information online is a common activity.


John M. Greene, MD

Latest:

Psychiatric Malpractice: Basic Issues in Evolving Contexts

This article focuses on 4 issues in psychiatric malpractice: prescribing, liability for suicide, informed consent, and duty to protect under the Tarasoff v Regents of the University of California ruling. Malpractice is a civil wrong actionable by law. There are 2 goals of malpractice suits: the first is to make an injured plaintiff whole by an award of money, and the second is to inform the profession how courts will decide similar cases in the future.


John M. Halphen, JD, MD

Latest:

Elder Abuse and Neglect: Appearances Can Be Deceptive

The number of persons affected by elder mistreatment and self-neglect is growing-with consequent increases in morbidity and premature mortality.


John M. Kane, MD

Latest:

Potential Novel Schizophrenia Treatments

A comprehensive discussion on new treatment options for patients with schizophrenia, highlighting the potential for earlier intervention to optimize treatment outcomes.


John M. Oldham, MD

Latest:

Marketing Off-Label Uses: Shady Practices Within a Gray Market

For pharmaceutical companies, off-label use of a drug represents a substantial “gray market,” to which the company is unable to sell their product directly, yet may be a significant revenue stream. Some drugs have been used more for off-label purposes than for originally approved indications.1


John Manring, MD

Latest:

No, Psychiatry Has Not Lost Its “Mind”: Here, Psychotherapy Training Thrives

After reading Dr Daniel Carlat’s heartfelt piece in the April 19, 2010, New York Times Magazine (“Mind Over Meds”), I was struck by several things. The first was Dr Carlat’s eloquence regarding the dilemmas of psychiatric practice. Second was how his experience may represent a generation of psychiatrists who were trained during an era of drug discovery wrapped in the exciting promise of “Biological Psychiatry.”


John Matochik, PhD

Latest:

Alcoholism Research and Neuroimaging: Implications for Treatment

Advances in basic molecular research of alcoholism await translation into important new clinical insights.


John Medina, PhD

Latest:

Neurobiology of PTSD

This is the last installment in a 3-part series discussing the behavioral, cellular, and molecular characteristics of posttraumatic stress disorder (PTSD). In Part 1, I described some basic clinical observations of PTSD and the challenges these observations pose to researchers attempting to understand underlying biological substrates.1 Part 2 examined progress on addressing these challenges at the level of the tissue and cell.2 In Part 3, I will discuss efforts to understand PTSD at the level of DNA, including potential genetic underpinnings and heritable risk factors.


John P. Murray, PhD

Latest:

TV Violence and Brainmapping in Children

Research conducted over the past 30 years leads to the conclusion that televised violence does influence viewers' attitudes, values and behavior.


John P. O’reardon, MD

Latest:

Atypical Depression in the 21st Century: Diagnostic and Treatment Issues

Identification of atypical features is important in the treatment of depression for both treatment selection and prognosis, especially when initial measures prove ineffective. The concept of atypical depression has evolved over many years, and now it appears timely for a further revision.


John P. Shand, MD

Latest:

Consent in Psychiatric Emergencies: What Clinicians Need to Know

It is important to recognize and document the abilities and deficits of a patient in order to determine capacity.


John R. Geddes, MD

Latest:

Antidepressants for Bipolar Disorder

What is the effectiveness (if any) of antidepressants in bipolar depression? What is the risk of manic switching? How effective are antidepressants in preventing relapse of bipolar depression? Insights here.



John S. Leipsic, MD

Latest:

The Internet as Practice Extender

In the early 1960s, the Internet was born out of the idea of a "Galactic Network." By the late 1980s, technology had advanced to allow for computer-based exchange of scientific information between academic and research institutes. From these humble beginnings, the Internet has experienced explosive growth in the last five years, evolving into a powerful global information resource and new media format unto itself. Psychiatrists can now reap the full benefit of this fast-paced evolution to extend the reach of their medical practice.


John Santopietro, MD

Latest:

Sweet Tea and Mental Health Transformation

Across our nation, mental health care funding and resources are either slashed to the bone or nonexistent. Yet, at the same time, there is a unique opportunity available right now for any and all who want to tackle reform.


John Sargent, MD

Latest:

Traumatic Stress in Children and AdolescentsEight Steps to Treatment

Traumatic experiences are common in childhood and adolescence and can have significant psychological effects on the child’s emotional well-being and overall development. Outcomes can be affected positively or negatively depending on responses and interventions.



John Torous, MD, MBI

Latest:

Integrating Mental Health Apps Into Care With Your Patients: What You Need to Know

Here’s everything you need to know to about how to integrate apps into your clinical practice.


John V. Campo, MD

Latest:

Addressing the Interface Between Pediatrics and Psychiatry

There has been much thought and discussion about the relationship between pediatrics and psychiatry, but research on the integration of the two leaves much to the imagination.


John W. Goethe, MD

Latest:

Does TMS Hold Promise for Generalized Anxiety Disorder?

Available data suggest that transcranial magnetic stimulation holds promise as a treatment for GAD. Here: a look at what we know.


John W. Thompson Jr, MD

Latest:

A Call to Arms to Understand and Treat Aggressive Behavior

Dr Thompson introduces a Special Report meant to provoke thoughtful contemplation on various topics related to aggressive behavior.


John W. Tsuang, MD

Latest:

An Update on Street and Club Drugs: What Clinicians Need to Know

A review of the pharmacological and symptomatic effects of various classes of designer drugs, including stimulants, hallucinogens, and sedatives.


John W. Williams Jr, MD

Latest:

Marketing Off-Label Uses: Shady Practices Within a Gray Market

For pharmaceutical companies, off-label use of a drug represents a substantial “gray market,” to which the company is unable to sell their product directly, yet may be a significant revenue stream. Some drugs have been used more for off-label purposes than for originally approved indications.1


John W. Winkelman, MD, PhD

Latest:

Restless Legs Syndrome: Clinical Implications for Psychiatrists

While patients with restless legs syndrome may be successfully treated with a number of medications, comorbid psychiatric conditions present a unique challenge because many commonly prescribed psychiatric medications may worsen RLS symptoms.


John Z. Sadler, MD

Latest:

Consequences of Population Drift

Writers of diagnostic criteria should consider their work and all its implications. What about adding a new disorder? What might that do to epidemiological capture? Depending on the characteristics of the diagnostic criteria set, many possibilities exist.


Johnny L. Matson, PhD

Latest:

Cormorbidity: Diagnosing Comorbid Psychiatric Conditions

Autism spectrum disorders (ASDs) are a group of 5 neuro developmental conditions (autism, Asperger syndrome, pervasive developmental disorder not otherwise specified [PDD-NOS], Rett syndrome, and disintegrative childhood disorder).1 Once thought to be rare, the incidence of these disorders is now estimated to be 1 in 150 children in the general population.2 Furthermore, the number of recognized cases has increased markedly in recent years.


Johnny L. Williamson, MD

Latest:

Challenges and Obstacles in Treating Mentally Ill Black Patients

As the United States becomes more culturally, racially, and ethnically diverse, psychiatry will be faced with the need to treat more diverse populations. This article focuses on challenges and obstacles encountered when treating black patients with mental illness.


Joji Suzuki, MD

Latest:

What All Psychiatrists Need to Know About Addictions

Because at least 10% of the US population suffers from a substance use disorder in any given year, the American Academy of Addiction Psychiatry has expanded its longstanding Board Review Course in Addictions to a more inclusive “Addictions and Their Treatment” course.


Jolene R. Bostwick, PharmD

Latest:

Metabolic Monitoring of Antipsychotic Medications: What Psychiatrists Need to Know

Because patients who have psychiatric illnesses typically receive less frequent medical care, psychiatrists must aim to ensure appropriate monitoring of metabolic parameters when antipsychotic medications are used.


Jolie S. Brams, PhD

Latest:

Managing Autism in Children

No other psychiatric diagnosis has more profound negative implications than autism. On the surface, autism impacts social, emotional, behavioral, and academic functioning. However, autism is pervasive in ways less immediately observable, and, as a result, children with autism require developmental and educational interventions that are different in both form and intensity from those required by children with other special needs.

© 2024 MJH Life Sciences

All rights reserved.